Steve Papermaster
Steve Papermaster (born September 27, 1958) is an American entrepreneur, health and technology innovator, and global speaker. He is Chairman and CEO of ,[1] a company focused on dramatically accelerating the development of cures for global health threats, including a leading Covid-19 vaccine and novel delivery platform.[2]
Papermaster was appointed (2001-2009) as a Senior Advisor by President George W. Bush and to serve on the United States President's Council of Advisors on Science and Technology (PCAST).[3] Under President Bush, he also helped lead the Human Genome Project, the National Nanotechnology Initiative, served as a member of the China-US Strategic Economic Dialogue(SED), and is currently co-Chairperson of the Joint US-China Collaboration on Clean Energy (JUCCCE).[4]
He was also the founder and CEO, board member and/or lead investor in technology, healthcare and biotechnology companies which achieved successful IPO's and/or merger and acquisition transactions. Papermaster has also serves as CEO of Powershift Ventures.[5]
Mr. Papermaster is a co-chairman and co-founder of the Ernst & Young (EY) World Entrepreneur of the Year Program and Global Societal Impact Award held annually in Monaco.
References[]
- ^ "Steve Papermaster". Nano. 25 March 2018. Retrieved 14 June 2019.
- ^ https://www.cnnmoney.ch/shows/newsmaker/videos/strong-relationship-roche-nanovision-ceo-steve-papermaster/
- ^ www.whitehouse.gov
- ^ "Archived copy". Archived from the original on 2012-09-11. Retrieved 2012-09-19.
{{cite web}}: CS1 maint: archived copy as title (link) - ^ "Steven G. Papermaster: Executive Profile & Biography - Bloomberg". www.bloomberg.com. Archived from the original on 2016-04-05. Retrieved 14 June 2019.
 | This article about an American businessperson born in the 1950s is a stub. You can help Wikipedia by . |
- American chief executives
- Living people
- 1958 births
- American business biography, 1950s birth stubs